Definition of Lupus Anticoagulant
Lupus anticoagulant is an antibody that reacts with phospholipids in the reagents for hemostasis tests, causing prolongation of the tests. 1, 2
Characteristics of Lupus Anticoagulant
Lupus anticoagulant (LA) is part of the antiphospholipid antibody family and has several key features:
- It consists of immunoglobulins (IgG, IgM, or both) that interfere with phospholipid-dependent coagulation tests 2
- Despite its name suggesting anticoagulation, LA is paradoxically associated with thrombotic events rather than bleeding 2, 3
- LA prolongs one or more in vitro phospholipid-dependent tests of coagulation, including:
- Activated Partial Thromboplastin Time (APTT)
- Dilute Russell's Viper Venom Time (dRVVT)
- Kaolin Clotting Time (KCT)
- Textarin Time (TT) 2
Laboratory Detection
The International Society on Thrombosis and Haemostasis recommends using two parallel tests for LA detection:
- dRVVT (highest specificity for detecting LA in high-risk thrombosis patients)
- LA-sensitive APTT with silica as activator 1
The diagnostic process follows a specific algorithm:
- Careful preparation of platelet-poor plasma is essential
- At least two screening tests must be performed
- Mixing studies are conducted to identify the presence of an inhibitor
- Confirmatory procedures demonstrate phospholipid-dependence of the inhibitor 2, 4
Clinical Significance
Understanding LA is critical because:
- Approximately 1/3 of individuals with LA experience thromboembolic complications (stroke, deep vein thrombosis, pulmonary emboli) 2
- LA is more strongly associated with thrombosis than other anticardiolipin antibodies 5
- LA can form immune complexes with prothrombin and phospholipids that may augment thrombin production, potentially explaining the thrombotic tendency 3
- LA testing is recommended in patients with antiphospholipid syndrome, particularly in young patients (<50 years) with unprovoked venous or arterial thrombosis, and in women with recurrent pregnancy loss 1
Common Pitfalls in LA Testing
- Not all APTT reagents have equal sensitivity to LA 1, 5
- Anticoagulant medications can interfere with test results 1
- Timing of testing is crucial - should be avoided during acute thrombosis or pregnancy 1
- Many laboratories still rely on poorly responsive screening assays, leading to misdiagnosis of weakly positive LA samples 5
- A single positive result is insufficient; confirmation requires repeat testing after >12 weeks 1
The definition that best describes lupus anticoagulant is therefore option B: an antibody that reacts with phospholipids in the reagents for hemostasis tests, causing prolongation of the tests.